Biogen (BIIB) PT Cut To $375 At Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst, Jay Olson, reiterated his Outperform rating on shares of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
